metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Gallbladder cancer in a regional hospital
Journal Information
Vol. 86. Issue 4.
Pages 219-223 (December 2009)
Share
Share
Download PDF
More article options
Vol. 86. Issue 4.
Pages 219-223 (December 2009)
Full text access
Gallbladder cancer in a regional hospital
Cáncer de vesícula biliar en un hospital comarcal
Visits
1293
Francisco José Morera Ocóna,
Corresponding author
fmoreraocon@aecirujanos.es

Corresponding author.
, Javier Ballestín Vicenteb, Francisco Ripoll Ortsa, Francisco Landete Molinaa, Mario García-Granero Ximéneza, José Millán Tarína, Leonardo de Tursi Rispoldia, Juan Carlos Bernal Sprekelsena
a Servicio de Cirugía General, Hospital de Requena, Valencia, Spain
b Servicio de Radiología, Hospital de Requena, Valencia, Spain
This item has received
Article information
Abstract
Objectives

To assess the management of gallbladder cancer (GBC) in our region.

Material and methods

Data on 372 patients who underwent cholecystectomy were identified from our database (January 2003 to February 2008) and 6 patients were found to have GBC.

Results

Four patients had incidental carcinoma, one case was preoperatively suspected, and one patient presented with jaundice and locally advanced neoplasia. The incidence was 2 per 100 000 inhabitants per year; incidental carcinoma in 1.1% of cholecystecomies. The ultrasonography showed multilithiasis in 2 patients, sludge and neoplasia in 1, gallstones more than 3cm in 2, and tumor mass only in 1 case. T stage: one case of T0 (in situ), 1 of T1, 2 of T2, and one T4. Incidental carcinomas were reoperated on when a T2 was established: two underwent lymphadenectomy and cystic stump resection, 1 segmentectomy IVb-V and lymphadenectomy. In the preoperative suspected neoplasia a cholecystectomy, lymphadenectomy, and partial hepatic gallbladder bed resection was initially performed.

Conclusions

GBC has a low incidence but it will be found in 1% of cholecystectomies. There is no adjuvant treatment and T-based surgical treatment is the only opportunity to reach cure in those patients. A national GBC database would be helpful in the publication of national guidelines for this disease.

Keywords:
Gallbladder cancer
Incidental carcinoma
Incidence
Resumen
Objetivo

Evaluar el tratamiento del cáncer de vesícula biliar (CVB) en nuestro medio.

Material y métodos

De 372 pacientes a los que se les realizó colecistectomía (enero de 2003 a febrero de 2007), 6 presentaron un CVB.

Resultados

En 4 casos el carcinoma fue incidental, en un paciente se tuvo sospecha diagnóstica antes de la colecistectomía, y un paciente comenzó con ictericia obstructiva secundaria a neoplasia avanzada. Incidencia: 2 casos por 100.000 habitantes por año; cáncer incidental en el 1,1% de las colecistectomías. La ecografía mostró multilitiasis en 2 pacientes, barro biliar y neoplasia en un paciente, litiasis mayor de 3cm en 2 pacientes y sólo masa tumoral en un paciente. Grados T: un caso T0 (in situ), un caso T1, 3 casos T2 y un caso T4. En los T2 incidentales se practicó ampliación quirúrgica: en 2, linfadenectomía, y en uno, segmentectomía IVb-V con linfadenectomía. En la sospecha preoperatoria se practicó colecistectomía, linfadenectomía y resección del lecho vesicular.

Conclusiones

El CVB presenta baja incidencia pero es un hallazgo incidental en el 1% de las colecistectomías. No existe tratamiento adyuvante, por lo que la cirugía basada en el grado T es la única oportunidad de curación. No es infrecuente que tumores supuestamente T2 sean luego T3 al existir células malignas en el lecho vesicular hepático. Su extirpación mantiene la oportunidad de curación. La creación de una base de datos nacional de cáncer de vesícula ayudaría a establecer recomendaciones terapéuticas propias para esta enfermedad.

Palabras clave:
Cáncer de vesícula biliar
Carcinoma incidental
Incidencia
Full text is only aviable in PDF
References
[1.]
Y. Fong, S. Malhptra.
Gallbladder cancer: recent advances and current guidelines for surgical therapy.
Adv Surg, 35 (2001), pp. 1-20
[2.]
D.L. Barlett, Y. Fong, J.G. Fortner, M.F. Brennan, L.H. Blumgart.
Long- term results alter resection for gallbladder cancer.
Ann Surg, 224 (1996), pp. 639-646
[3.]
C.D. Sun, B.Y. Zhang, L.Q. Wu, W.J. Lee.
Laparoscopic cholecystectomy for treatment of unexpected early-stage gallbladder cancer.
J Surg Oncol, 91 (2005), pp. 253-267
[4.]
K. Chijiiwa, K. Nakano, J. Ueda, H. Noshiro, E. Nagai, K. Yamaquchi, et al.
Surgical treatment of patients with T2 gallbladder carcimona invading subserosal layer.
J Am Coll Surg, 192 (2001), pp. 600-607
[5.]
T. Wakai, Y. Shirai, K. Hatakeyama.
Radical second resection provided survival benefit for patients with T2 gallbladder carcinoma.
World J Surg, 26 (2002), pp. 867-871
[6.]
B.E. Wright, C.C. Lee, D.M. Iddings, M. Kavanagh, A.J. Bilchick.
Management of T2 gallbladder cancer: are practice pattern consistent with national recommendations?.
Am J Surg, 194 (2007), pp. 820-826
[7.]
J.H. Donohue, Stewart, H.R. Mernck.
The Natinonal Cancer Database report on carcninoma of the gallbladder, 1989–1995.
Cancer, 83 (1998), pp. 2618-2628
[8.]
A. Ríos Zambudio, F. Sánchez Bueno, J.A. García Marcilla, R. Robles Campos, M.E. Tamayo Rodríguez, M.D. Balsalobre Salmerón, et al.
Factores pronósticos en cáncer de vesícula biliar.
Gastroenterol Hepatol, 24 (2001), pp. 281-286
[9.]
Y. Fong, L. Wagman, M. Gonen, J. Crawford, W. Reed, R. Swanson, et al.
Evidence-based gallbladder cancer staging.
[10.]
S.P. Shih, R.D. Schulick, J.L. Cameron, K.D. Lillemoe, H.A. Pitt, M.A. Choti, et al.
Gallbladder cancer: the role of laparoscopy and radical resection.
Ann Surg, 245 (2007), pp. 893-901
[11.]
H. Wakabayashi, K. Ishimura, N. Hashimoto, T. Otani, A. Kondo, H. Maeta.
Analysis of prognostic factors alter surgery for stage III and IV gallbladder cancer.
[12.]
J. de la Cruz, L.A. Hidalgo, J. Feliu, C. Admella, M. del Bas, X. Suñol.
Adenocarcinoma de vesícula biliar: estadio tumoral, factores pronósticos histológicos y supervivencia.
Cir Esp, 77 (2005), pp. 18-21
[13.]
T.O. Goetze, V. Paolucci.
Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: análisis of the german registry.
Ann Surg, 247 (2008), pp. 104-108
[14.]
T.M. Pawlik, A.L. Gleisner, L. Vigano, D.A. Kooby, T.W. Bauer, A. Frilling, et al.
Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection.
J Gastrointest Surg, 11 (2007), pp. 1478-1486
[15.]
A. Frena, P. Marinillo, G. La Guardia, F. Martin.
[Incidental gallbladder carcinoma].
Chir Ital, 59 (2007), pp. 185-190
[16.]
A.F. Hezel, A.X. Zhu.
Systemic therapy for biliary tract cancers.
The Oncologist, 13 (2008), pp. 415-423
[17.]
J.M. Ramia, A. Palomeque, A. Fernández, K. Muffak, J. Villar, D. Garrote, et al.
La imagen del mes.
Cir Esp, 77 (2005), pp. 54
Copyright © 2009. Asociación Española de Cirujanos
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos